Seminars in Oncology
Volume 32, Issue 1 , Pages 76-84 , February 2005

Colorectal cancer vaccines: What we know and what we don’t yet know

  • Margaret von Mehren

      Affiliations

    • Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA
    • Corresponding Author InformationAddress reprint requests to Margaret von Mehren, MD, Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA 19111

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported in part by 1R21 CA92992-01. Dr von Mehren has served as an advisor to Aventis-Pasteur and Novartis Oncology. She received less than $5,000 in honoraria from each company in 2003.

PII: S0093-7754(04)00462-2

doi: 10.1053/j.seminoncol.2004.09.033

Seminars in Oncology
Volume 32, Issue 1 , Pages 76-84 , February 2005

Article Tools

* Image Usage & Resolution